Currently, treatment is given based on symptoms such as cough, fever and sore throat. - Reuters
SINGAPORE (The Straits Times/Asia News Network): Paxlovid, a new antiviral pill to treat Covid-19, will be rolled out at selected polyclinics and Public Health Preparedness Clinics (PHPCs) in phases to patients to reduce their likelihood of hospitalisation.
This is the first Covid-19 pill approved by the Health Sciences Authority (HSA) for use here. HSA noted that Pfizer’s clinical studies showed that there were few instances of side effects.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
